Did you know?

About Adverum Biotechnologies Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases ...4 Wall Street research analysts have issued 1 year price targets for Adverum Biotechnologies' stock. Their ADVM share price targets range from $2.00 to $6.00. On average, they anticipate the company's share price to reach $3.50 in the next year. This suggests a possible upside of 297.9% from the stock's current price.The ADVM stock price fell by -1.38% on the last day (Thursday, 30th Nov 2023) from $0.82 to $0.81. During the last trading day the stock fluctuated 6.25% from a day low at $0.80 to a day high of $0.85. The price has been going up and down for this period, and there has been a -8.11% loss for the last 2 weeks.(NASDAQ: ADVM) Adverum Biotechnologies currently has 100,993,010 outstanding shares. With Adverum Biotechnologies stock trading at $0.91 per share, the total value of Adverum Biotechnologies stock (market capitalization) is $91.90M.So, the natural question for Adverum Biotechnologies (NASDAQ:ADVM) shareholders is whether they should be concerned by its rate of cash burn. For the purposes of this article, cash burn is the ...Find the latest Insider Activity data for Adverum Biotechnologies, Inc. Common Stock (ADVM) at Nasdaq.com.See All Market Activity. News + Insights. CLOSEAccording to the issued ratings of 4 analysts in the last year, the consensus rating for Adverum Biotechnologies stock is Buy based on the current 4 buy ratings for ADVM. The average twelve-month price prediction for Adverum Biotechnologies is $3.50 with a high price target of $6.00 and a low price target of $2.00.The latest price target for Adverum Biotechnologies ( NASDAQ: ADVM) was reported by Mizuho on Thursday, November 2, 2023. The analyst firm set a price target for 2.00 expecting ADVM to rise to ...Find the latest Financials data for Adverum Biotechnologies, Inc. Common Stock (ADVM) at Nasdaq.com.Nov 4, 2023 · Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Jul 22, 2021 · Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of patients with wet age-related macular degeneration. Vanguard Total Stock Market ETF. $2.50M. 8. DFAC. Dimensional U.S. Core Equity 2 ETF. $3.44K. 8. ITOT. iShares Core S&P Total U.S. Stock Market ETF. $97.20.Sep 12, 2019 · MENLO PARK, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases ... Earnings announcement* for ADVM: Aug 04, 2022. Adverum Biotechnologies, Inc. is estimated to report earnings on 08/04/2022. The upcoming earnings date is derived from an algorithm based on a ...Adverum Biotechnologies (NASDAQ: ADVM) is a clinicalApr 28, 2020 · Momentum investing revolves around the id Find the latest Institutional Holdings data for Adverum Biotechnologies, Inc. Common Stock (ADVM) at Nasdaq.com. In 2006 he co-founded and served as Chairman of the Board of Adver We'd be surprised if Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shareholders haven't noticed that the Independent Director, James Scopa, recently sold US$109k worth of stock at US$2.18 per share. Find the latest Insider Activity data for Adverum Biotechnolo

Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of ...About Adverum Biotechnologies Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs in serious ocular and rare diseases. Adverum is ...The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...Overview Stock Screener Earnings Calendar Sectors Nasdaq | ADVM U.S.: Nasdaq Adverum Biotechnologies Inc. Watch Set a price target alert After Hours Last Updated: …Adverum Biotechnologies, Inc. Common Stock (ADVM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Find the latest Insider Activity data for Adverum Biotechnologies, Inc. Common Stock (ADVM) at Nasdaq.com.Adverum Biotechnologies Inc stock price (ADVM) NASDAQ: ADVM. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Adverum Biotechnologies Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Adverum Biotechnologies (ADVM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Adverum Biotechnologies, Inc. Common Stock (ADVM) Historical. Possible cause: ADVM U.S.: Nasdaq Adverum Biotechnologies Inc. Watch Set a price target alert After H.